Left Brain Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Left Brain Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-402	Closed	-$223K	–	86
2023 Q1	$223K	Sell	402 -39	-9%	-$22K	0.15%	75
2022 Q4	$243K	Buy	+441	New	+$234K	0.18%	61

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Left Brain Wealth Management's TMO Position: Q2 2023 in Review

Left Brain Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 402 shares — an estimated $223K sold.

Left Brain Wealth Management first reported a position in TMO in Q4 2022 and held it in 2 quarters. The position peaked at $243K in Q4 2022. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Left Brain Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
Left Brain Wealth Management sold 402 Thermo Fisher Scientific shares in Q2 2023, an estimated $223K.
Left Brain Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 2 quarters.
Left Brain Wealth Management's Thermo Fisher Scientific position peaked at $243K in Q4 2022.
2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Left Brain Wealth Management's 13F filing for Q2 2023, filed 4 Aug 2023.